Pfizer on Monday proposed a $99 billion acquisition of its British rival AstraZeneca, a move that would allow Pfizer to tap into a mountain of cash trapped overseas.
via NYT > Business Day http://ift.tt/1j5SoX1
via WordPress http://ift.tt/1iC988G
via All Business Is Good Business http://ift.tt/1nZyQnE
via May 21st 2011 wrong http://ift.tt/1tZFjTG
No comments:
Post a Comment